{
    "paper_id": "PMC3847673",
    "metadata": {
        "title": "DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease",
        "authors": [
            {
                "first": "Michael",
                "middle": [
                    "A"
                ],
                "last": "Portman",
                "suffix": "",
                "email": "Michael.portman@seattlechildrens.org",
                "affiliation": {}
            },
            {
                "first": "Howard",
                "middle": [
                    "W"
                ],
                "last": "Wiener",
                "suffix": "",
                "email": "hwiener@uab.edu",
                "affiliation": {}
            },
            {
                "first": "Miriam",
                "middle": [],
                "last": "Silva",
                "suffix": "",
                "email": "miriam.silva@seattlechildrens.org",
                "affiliation": {}
            },
            {
                "first": "Aditi",
                "middle": [],
                "last": "Shendre",
                "suffix": "",
                "email": "draditi@uab.edu",
                "affiliation": {}
            },
            {
                "first": "Sadeep",
                "middle": [],
                "last": "Shrestha",
                "suffix": "",
                "email": "sshrestha@uab.edu",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "The parent study and this genetic sub-study conformed to the procedures for informed consent (parental permission) approved by institutional review boards at all sponsoring organizations and to human-experimentation guidelines set forth by the United States Department of Health and Human Services.",
            "cite_spans": [],
            "section": "Ethical approval ::: Findings",
            "ref_spans": []
        },
        {
            "text": "All the authors declare that there are no competing interests.",
            "cite_spans": [],
            "section": "Competing interests",
            "ref_spans": []
        },
        {
            "text": "MAP and SS conceived, designed and led the study. AS assisted with the SNP genotyping and managed the genetic data. MS managed the clinical data and assisted with recruitment of patients. HWW performed the analysis and both AS and HWW assisted with the interpretation of the genetic analysis results. MAP and SS wrote the manuscript, and all authors participated in drafting the manuscript to the final version. All authors read and approved the final manuscript.",
            "cite_spans": [],
            "section": "Authors\u2019 contributions",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: PCR and pyrosequencing primers used in the analysis of promoter variants in DC-SIGN\n*Nucleotide position as described in Martin et al. [14]; \u2020 second variant in small letters is the minor allele as described in HapMap Whites.",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Allele and genotype distribution of five polymorphisms in the promoter of DC-SIGN among IVIG responders and non-responders in three ethnic groups\n*For Hispanics, the frequency from the Hapmap Mexican population is shown; OR based on the additive model for minor allele.",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children",
            "authors": [],
            "year": 1967,
            "venue": "Arerugi",
            "volume": "16",
            "issn": "3",
            "pages": "178-222",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor",
            "authors": [],
            "year": 2001,
            "venue": "Science",
            "volume": "291",
            "issn": "5503",
            "pages": "484-486",
            "other_ids": {
                "DOI": [
                    "10.1126/science.291.5503.484"
                ]
            }
        },
        "BIBREF2": {
            "title": "Identification of a receptor required for the anti-inflammatory activity of IVIG",
            "authors": [],
            "year": 2008,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "105",
            "issn": "50",
            "pages": "19571-19578",
            "other_ids": {
                "DOI": [
                    "10.1073/pnas.0810163105"
                ]
            }
        },
        "BIBREF3": {
            "title": "A variant in the CD209 (DC-SIGN) promoter is associated with severity of dengue disease",
            "authors": [],
            "year": 2005,
            "venue": "Med Sci (Paris)",
            "volume": "21",
            "issn": "11",
            "pages": "905-906",
            "other_ids": {
                "DOI": [
                    "10.1051/medsci/20052111905"
                ]
            }
        },
        "BIBREF4": {
            "title": "Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis",
            "authors": [],
            "year": 2006,
            "venue": "Hum Immunol",
            "volume": "67",
            "issn": "10",
            "pages": "808-811",
            "other_ids": {
                "DOI": [
                    "10.1016/j.humimm.2006.07.003"
                ]
            }
        },
        "BIBREF5": {
            "title": "Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection",
            "authors": [],
            "year": 2004,
            "venue": "J Virol",
            "volume": "78",
            "issn": "24",
            "pages": "14053-14056",
            "other_ids": {
                "DOI": [
                    "10.1128/JVI.78.24.14053-14056.2004"
                ]
            }
        },
        "BIBREF6": {
            "title": "Role of activating FcgammaR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response",
            "authors": [],
            "year": 2012,
            "venue": "Circ Cardiovasc Genet",
            "volume": "5",
            "issn": "3",
            "pages": "309-316",
            "other_ids": {
                "DOI": [
                    "10.1161/CIRCGENETICS.111.962464"
                ]
            }
        },
        "BIBREF7": {
            "title": "Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease",
            "authors": [],
            "year": 2011,
            "venue": "J Allergy Clin Immunol",
            "volume": "128",
            "issn": "3",
            "pages": "677-680",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jaci.2011.04.027"
                ]
            }
        },
        "BIBREF8": {
            "title": "A variant in the CD209 promoter is associated with severity of dengue disease",
            "authors": [],
            "year": 2005,
            "venue": "Nat Genet",
            "volume": "37",
            "issn": "5",
            "pages": "507-513",
            "other_ids": {
                "DOI": [
                    "10.1038/ng1550"
                ]
            }
        },
        "BIBREF9": {
            "title": "Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis",
            "authors": [],
            "year": 2006,
            "venue": "PLoS Med",
            "volume": "3",
            "issn": "2",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pmed.0030020"
                ]
            }
        },
        "BIBREF10": {
            "title": "Naturally-occurring genetic variants in human DC-SIGN increase HIV-1 capture, cell-transfer and risk of mother-to-child transmission",
            "authors": [],
            "year": 2012,
            "venue": "PLoS One",
            "volume": "7",
            "issn": "7",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0040706"
                ]
            }
        },
        "BIBREF11": {
            "title": "Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas",
            "authors": [],
            "year": 2011,
            "venue": "Pediatr Rheumatol Online J",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1186/1546-0096-9-17"
                ]
            }
        },
        "BIBREF12": {
            "title": "CD209 (DC-SIGN) -336A\u2009>\u2009G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese",
            "authors": [],
            "year": 2010,
            "venue": "Hum Immunol",
            "volume": "71",
            "issn": "7",
            "pages": "702-707",
            "other_ids": {
                "DOI": [
                    "10.1016/j.humimm.2010.03.006"
                ]
            }
        },
        "BIBREF13": {
            "title": "Polymorphic variants in DC-SIGN, DC-SIGNR and SDF-1 in high risk seronegative and HIV-1 patients in Northern Asian Indians",
            "authors": [],
            "year": 2008,
            "venue": "J Clin Virol",
            "volume": "43",
            "issn": "2",
            "pages": "196-201",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jcv.2008.06.005"
                ]
            }
        },
        "BIBREF14": {
            "title": "DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation",
            "authors": [],
            "year": 2011,
            "venue": "PLoS Negl Trop Dis",
            "volume": "5",
            "issn": "1",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pntd.0000934"
                ]
            }
        },
        "BIBREF15": {
            "title": "Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young. American Heart Association",
            "authors": [],
            "year": 2004,
            "venue": "Circulation",
            "volume": "110",
            "issn": "17",
            "pages": "2747-2771",
            "other_ids": {
                "DOI": [
                    "10.1161/01.CIR.0000145143.19711.78"
                ]
            }
        },
        "BIBREF16": {
            "title": "DC-SIGN (CD209) promoter -336 A/G (rs4804803) polymorphism associated with susceptibility of Kawasaki disease",
            "authors": [],
            "year": 2012,
            "venue": "Sci World J",
            "volume": "2012",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007",
            "authors": [],
            "year": 2010,
            "venue": "Pediatr Infect Dis J",
            "volume": "29",
            "issn": "6",
            "pages": "483-488",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Intravenous gamma-globulin treatment and retreatment in Kawasaki disease",
            "authors": [],
            "year": 1998,
            "venue": "Pediatr Infect Dis J",
            "volume": "17",
            "issn": "12",
            "pages": "1144-1148",
            "other_ids": {
                "DOI": [
                    "10.1097/00006454-199812000-00009"
                ]
            }
        },
        "BIBREF19": {
            "title": "FcgammaR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response",
            "authors": [],
            "year": 2013,
            "venue": "Pharmacogenet Genomics",
            "volume": "23",
            "issn": "9",
            "pages": "455-462",
            "other_ids": {
                "DOI": [
                    "10.1097/FPC.0b013e328363686e"
                ]
            }
        },
        "BIBREF20": {
            "title": "High-dose intravenous gammaglobulin for Kawasaki disease",
            "authors": [],
            "year": 1984,
            "venue": "Lancet",
            "volume": "2",
            "issn": "8411",
            "pages": "1055-1058",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome",
            "authors": [],
            "year": 1991,
            "venue": "N Engl J Med",
            "volume": "324",
            "issn": "23",
            "pages": "1633-1639",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJM199106063242305"
                ]
            }
        },
        "BIBREF22": {
            "title": "The treatment of Kawasaki syndrome with intravenous gamma globulin",
            "authors": [],
            "year": 1986,
            "venue": "N Engl J Med",
            "volume": "315",
            "issn": "6",
            "pages": "341-347",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJM198608073150601"
                ]
            }
        },
        "BIBREF23": {
            "title": "Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young. American Heart Association",
            "authors": [],
            "year": 2004,
            "venue": "Pediatrics",
            "volume": "114",
            "issn": "6",
            "pages": "1708-1733",
            "other_ids": {
                "DOI": [
                    "10.1542/peds.2004-2182"
                ]
            }
        },
        "BIBREF24": {
            "title": "Infliximab treatment for refractory Kawasaki syndrome",
            "authors": [],
            "year": 2005,
            "venue": "J Pediatr",
            "volume": "146",
            "issn": "5",
            "pages": "662-667",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jpeds.2004.12.022"
                ]
            }
        },
        "BIBREF25": {
            "title": "Etanercept as adjunctive treatment for acute Kawasaki disease: study design and rationale",
            "authors": [],
            "year": 2011,
            "venue": "Am Heart J",
            "volume": "161",
            "issn": "3",
            "pages": "494-499",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ahj.2010.12.003"
                ]
            }
        },
        "BIBREF26": {
            "title": "Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation",
            "authors": [],
            "year": 2006,
            "venue": "Science",
            "volume": "313",
            "issn": "5787",
            "pages": "670-673",
            "other_ids": {
                "DOI": [
                    "10.1126/science.1129594"
                ]
            }
        }
    }
}